Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
drug discovery
treatments for human disease |
| gptkbp:founded |
1995
|
| gptkbp:founder |
gptkb:Alan_J._Garber
gptkb:Arthur_T._Sands gptkb:Brian_P._Zambrowicz gptkb:Raymond_Debbane |
| gptkbp:headquartersLocation |
gptkb:The_Woodlands,_Texas,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lexicon Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Lonnel_Coats
|
| gptkbp:numberOfEmployees |
approximately 200
|
| gptkbp:product |
gptkb:Sotagliflozin
gptkb:Xermelo |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:LXRX
|
| gptkbp:tradedOn |
gptkb:NASDAQ:LXRX
|
| gptkbp:website |
https://www.lexpharma.com/
|
| gptkbp:bfsParent |
gptkb:The_Woodlands,_Texas,_United_States
|
| gptkbp:bfsLayer |
5
|